Morphic Holding, Inc. (MORF): Investors Investigation

Investigation

Continous Holding
January 1, 2022 to April 10, 2023

Proposed Claim
Breach of Fiduciary Duty

This is a confidential investigation of certain directors & officers of Morphic Holding, Inc. (MORF) regarding a potential breach of fiduciary duties to the company and its shareholders.

Morphic Holding, Inc. (MORF) investors and shareholders are invited to contact the law firm below for additional information.

Brios is not a law firm and does not make any representation or judgment as to the qualifications, expertise, or credentials of any law firm advertising on our website, please refer to our terms and conditions for further information.

Main Event

Annual Shareholder Meeting

04/21/2023

SEC Filing

Morphic Holding, Inc. (MORF) files its proxy materials with the SEC for its 2023 annual meeting to be held on Thursday, June 1, 2023.

The stock impact compares the closing price immediately preceding the date of the event and the following closing price. The price difference also reflects the overall mix of information.

Stock Impact

Close	Previous close	Price variation	Percentage variation
$44.82	$43.17	$1.65	3.82%

See more on Factual Timeline

Resolution

We have marked this investigation as closed.

Why was the case resolved?

The stockholders annual meeting took place.
On 06/02/2023 the company issued the following statement:

On June 1, 2023, Morphic Holding, Inc. (the “Company”) held its 2023 Annual Meeting of Stockholders (the “Annual Meeting”), at which the matters listed below were submitted to a vote of the Company’s stockholders. There were 38,438,654 shares of common stock present at the Annual Meeting in person or by proxy, which represented approximately 97.0% of the voting power of the shares of common stock entitled to vote at the Annual Meeting and constituted a quorum for the transaction of business. Holders of the Company’s common stock were entitled to one vote for each share held as of the close of business on April 10, 2023. A detailed description of each of the proposals is included in the Company’s definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on April 21, 2023.

Source

Form 8-K